Effects of the lifestyle intervention program GLICEMIA in people at risk for type 2 diabetes: A cluster-randomized controlled trial

Diabetes Care

Volumn 38, Issue 5, 2015, Pages 937-939

  Schmiedel, Karin ^a   Mayr, Andreas ^b   Fießler, Cornelia ^b   Schlager, Helmut ^a   Friedland, Kristina ^b  

^a Scientific Institute for Prevention in Health Care (WIPIG)   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; CONTROLLED STUDY; COUNSELING; DIETARY INTAKE; DISEASE COURSE; FEMALE; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PROGRAM FEASIBILITY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; BEHAVIOR THERAPY; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEASIBILITY STUDY; LIFESTYLE; MIDDLE AGED; PHARMACY; PHYSIOLOGY; PROCEDURES; RISK FACTOR; RISK REDUCTION;

ADULT; BEHAVIOR THERAPY; CLUSTER ANALYSIS; COMMUNITY PHARMACY SERVICES; COUNSELING; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EXERCISE; FEASIBILITY STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84937408449     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2206     Document Type: Article

References (11)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-321
2. Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 2014;37:922-933
3. Schmiedel K, Schlager H, Dörje F. Preventive counselling for public health in pharmacies in South Germany. Int J Clin Pharmacol 2013;35:138-144
4. German Pharmacies: Figures, Data, Facts 2013 [article online], 2013. Available from http://www.abda.de/fileadmin/assets/ZDF/ZDF-2013/ABDA-ZDF-2013-Brosch-engl.pdf. Accessed 9 June 2014
5. Preventing Type 2 Diabetes: Population and Community-Level Interventions in High-Risk Groups and the General Population. NICE Public Health Guidance 35. London, National Institute for Health and Care Excellence, 2011
6. Schmiedel K, Schlager H, Leuner K. GLICEMIA - a randomised, controlled trial to assess the effects of a pharmacy-based prevention programme for persons at risk for type 2 diabetes mellitus. In Conference Book: Annual Meeting of the German Pharmaceutical Society, Freiburg, Germany, 2013. Frankfurt, Germany, German Pharmaceutical Society, p. 149
7. Paulweber B, Valensi P, Lindström J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010;42(Suppl. 1):S3-S36
8. Federal Union of German Associations of Pharmacists. Blood Pressure Measurement in the Pharmacy. Standard Operating Procedure (SOP) for the Pharmacy. Berlin, Germany, Center for Drug Information and Pharmacy Practice, 2009 [in German]
9. Federal Union of German Associations of Pharmacists. Guideline of the Federal Chamber of Pharmacists for Quality Assurance. Physiologically-Chemical Analysis: Implementation of Blood Tests. Berlin, Germany, Federal Chamber of Pharmacists, 2010 [in German]
10. Krems C, Bauch A, Götz A, et al. Methoden der nationalen Verzehrsstudie II. Ernährungs-Umschau 2006;53:44-50
11. Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 2007;39:677-682